Copyright
©2014 Baishideng Publishing Group Inc.
World J Biol Chem. Aug 26, 2014; 5(3): 286-300
Published online Aug 26, 2014. doi: 10.4331/wjbc.v5.i3.286
Published online Aug 26, 2014. doi: 10.4331/wjbc.v5.i3.286
Serum marker(s) | Ref. | Sensitivity (%) | Specificity (%) |
CA-125 | 1Karlsen et al[44] | 91.7 | 75 |
1Chan et al[47] | 90.8 | 67.2 | |
1Leung et al[123] | 89 | 90 | |
1Sandri et al[46] | 84.4 | 80 | |
1Montagnana et al[54] | 83 | 100 | |
1Sandri et al[46] | 73.1 | 90 | |
Yang et al[55] | 62.5 | 80 | |
Havrilesky et al[56] | 45.9-58.5 | 98.2 | |
1Moore et al[37] | 43.3 | 95 | |
Jacob et al[57] | 12.5 | 90.1-93.9 | |
HE-4 | 1Montagnana et al[54] | 98 | 100 |
Yang et al[55] | 96.2 | 83.8 | |
1Karlsen et al[44] | 91.3 | 75 | |
1Sandri et al[46] | 83.1 | 90 | |
Havrilesky et al[56] | 82.7-92.5 | 86.3 | |
1Moore et al[37] | 72.9 | 95 | |
Jacob et al[57] | 62.5 | 81.8-85.9 | |
1Chan et al[47] | 56.9 | 96.9 | |
CA-125, HE-4 | 1Moore et al[37] | 76.4 | 95 |
1Moore et al[41] | 88.7 | 74.7 | |
CA 125, leptin, PRL, OPN, IGFII, MIF | Visintin et al[58] | 95.3 | 99.4 |
CA 125, CRP, SAA, IL-6, IL-8 | Edgell et al[59] | 94.1 | 91.3 |
CA-125, apoA-I, TTR, TF | Su et al[60] | 89-97 | 91-99 |
CA 125, HE4, CEA, VCAM-1 | Yurkovetsky et al[61] | 86–93 | 98 |
CA 125, ApoA1, TTR | Kim et al[62] | 93.9 | 95 |
Zhang et al[42] | 74 | 97 | |
CA 125, CA 19-9, EGFR, CRP, myoglobin, ApoA1, ApoCIII, MIP-1a, IL-6, IL-18, tenascin C | 1Amonkar et al[63] | 91.3 | 88.5 |
CA-125, OVX1r, LASA,CA15-3, CA72-4 | Nossov et al[11] | 90.6 | 93.2 |
CA 125, CA 72-4, CA 15-3, M-CSF | 1Skates et al[64] | 70 | 98 |
LPA | Nossov et al[11] | 90-100 | 90 |
FOLR1 | 1Leung et al[123] | 62 | 90 |
M-CSF | Nossov et al[11] | 61-68 | 93 |
SMRP | 1Moore et al[37] | 53.7 | 95 |
- Citation: Cohen JG, White M, Cruz A, Farias-Eisner R. In 2014, can we do better than CA125 in the early detection of ovarian cancer? World J Biol Chem 2014; 5(3): 286-300
- URL: https://www.wjgnet.com/1949-8454/full/v5/i3/286.htm
- DOI: https://dx.doi.org/10.4331/wjbc.v5.i3.286